Analyst Reco. Oscar Health, Inc.

Equities

OSCR

US6877931096

Market Closed - Nyse Other stock markets 16:00:02 2024-04-26 EDT			5-day change	1st Jan Change
17.56 ^USD	-1.84%		+9.68%	+91.91%

03-22	Raymond James Starts Oscar Health With Outperform Rating, $20 Price Target	MT
03-18	Oscar Health, Inc.(NYSE:OSCR) added to S&P Insurance Select Industry Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Raymond James Starts Oscar Health With Outperform Rating, $20 Price Target	03-22	MT
Goldman Sachs Adjusts Price Target on Oscar Health to $16 From $8, Keeps Neutral Rating	02-09	MT
BofA Upgrades Oscar Health to Buy From Neutral, Adjusts Price Target to $9 From $8	11-02	MT
Morgan Stanley Raises Price Target on Oscar Health to $7.50 From $5, Maintains Equalweight Rating	23-08-30	MT
Goldman Sachs Adjusts Price Target on Oscar Health to $7.50 From $5.50, Keeps Neutral Rating	23-08-10	MT
Credit Suisse Adjusts Oscar Health's Price Target to $8.50 From $7, Keeps Outperform Rating	23-08-09	MT
Wells Fargo Adjusts Price Target on Oscar Health to $12 From $8.50, Maintains Overweight Rating	23-06-13	MT
BofA Securities Upgrades Oscar Health to Neutral From Underperform, Adjusts Price Target to $8.75 From $5.40	23-06-06	MT
Wells Fargo Raises Price Target on Oscar Health to $8.50 From $6.75, Maintains Overweight Rating	23-05-17	MT
Credit Suisse Lifts Oscar Health's Price Target to $7 From $6 After Above-Consensus Q1 Results, Keeps Outperform Rating	23-05-10	MT
Cowen Adjusts Price Target on Oscar Health to $6 From $3, Maintains Market Perform Rating	23-02-14	MT
Credit Suisse Trims Oscar Health's Price Target to $6 From $7, Keeps Outperform Rating	23-02-10	MT
Credit Suisse Trims Oscar Health's Price Target to $7 From $8, Keeps Outperform Rating	22-11-21	MT
Wells Fargo Upgrades Oscar Health to Overweight From Equal Weight, Price Target is $4	22-11-16	MT
Morgan Stanley Downgrades Oscar Health to Equalweight Rating From Overweight, Adjusts Price Target to $5 From $9	22-11-14	MT
Morgan Stanley Trims Price Target on Oscar Health to $9 From $12, Maintains Overweight Rating	22-09-01	MT
Credit Suisse Lowers Oscar Health's PT to $8 from $10 to Reflect Recent Developments in Managed Care Market, Maintains Outperform Rating	22-06-16	MT
BofA Securities Downgrades Oscar Health to Underperform From Neutral, Adjusts Price Target to $4.50 From $6	22-06-15	MT
BofA Securities Downgrades Oscar Health to Underperform From Neutral	22-06-15	MT
Morgan Stanley Adjusts Price Target for Oscar Health to $12 From $18, Maintains Overweight Rating	22-06-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Oscar Health, Inc.

Equities

OSCR

US6877931096

Analyst Reco.

Filters